Canada: New Premarket Requirements Aimed at Reducing Medication Errors

International Pharmaceutical Regulatory Monitor
A A
Starting next year, drug companies seeking to market products in Canada will need to provide the regulatory authority with information on proposed names, labels and packages.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00